Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial

 Drug distributors, J&J agree to finalize $26 bln opioid settlement

                  

The three largest U.S. drug distributors and drugmaker Johnson & Johnson have agreed to finalize a proposed $26 billion settlement resolving claims by states and local governments that they helped fuel the U.S. opioid epidemic.

Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial (Published 2019)

Oklahoma pursued the first case against a drug manufacturer for the national public health disaster, and the ruling may point to what lies ahead in 2,000 more lawsuits.

 

https://www.jnj.com/johnson-johnson-reaches-opioid-settlement-agreement-with-new-york-state-consistent-with-terms-of-previously-announced-broader-settlement-agreement-in-principle

Content Lab U.S.

Johnson & Johnson Reaches Opioid Settlement Agreement with New York State Consistent with Terms of Previously Announced Broader…